[
    [
        {
            "time": "",
            "original_text": "万泰生物IPO苦候三月获批 “独狼”钟睒睒面临资本新课题",
            "features": {
                "keywords": [
                    "万泰生物",
                    "IPO",
                    "获批",
                    "钟睒睒",
                    "资本",
                    "新课题"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]